Skip to content

Evaluation of the Ipelvis Application in Women's Urinary Loss

Evaluation of the Ipelvis Application on feminine urinary disfunctions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7pc86g
Enrollment
Unknown
Registered
2018-05-21
Start date
2017-01-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence, Urgency Urinary Incontinence

Interventions

Control Group: 35 volunteers will receive a sheet with exercises guidelines for Pelvic Floor Musculature (MAP) to be performed during 3 months at home
Experimental Group I: 35 volunteers will receive the Ipelvis application with exercise guidelines for MAP to be performed during 3 months at home
Experimental Group II: 35 volunteers will perform 12 sessions of 45 minutes, once a week, of Pelvic Physiotherapy in groups of a maximum of 10 participants. During the visits, exercises will be perfor
Other
H02.010.625

Sponsors

Faculdade Inspirar
Lead Sponsor
Hospital de Clínicas - Universidade Federal do Paraná
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Urinary urgency; stress and mixed urinary incontinence; with ages between 18 and 59 years, with objective demonstration of urinary loss that have cognitive ability; have a compatible cell phone for installation of the Ipelvis application and who sign the Informed Consent Term

Exclusion criteria

Exclusion criteria: They shall be excluded from the statistical analysis women with up to six months postpartum; women with prolapse greater than Stage III by Pelvic Organ Prolapse - Quantification; women with urinary tract infection; women with pelvic pain that prevent achievement Of therapies offered or who have undergone pelvic surgery in a period of less than six months; Pacemaker or contraceptive device; Women with intrapelvic tumor

Design outcomes

Primary

MeasureTime frame
Improvement of urinary symptoms, determined through the International Consultation on Incontinence Questionnaire, at the beginning and at the end of the study

Secondary

MeasureTime frame
Adherence of the patients to the physiotherapeutic treatment, related to the reduction or not of the urinary symptoms

Countries

Brazil

Contacts

Public ContactCíntia Blosfeld

Faculdade Inspirar

cintiaef@gmail.com+55-041-988659449

Outcome results

None listed

Source: REBEC (via WHO ICTRP)